Clones of erythroleukemic cells differ in the extent to which they (1) undergo differentiation spontaneously and (2) can be induced to differentiate in the presence of dimethylsulfoxide. Here we demonstrate that relative differences in globin gene expression within and between clones largely reflect differences in the proportion of cells participating in differentiation rather than uniform differences in the extent to which all cells in these clones undergo differentiation. We call this phenotype of a clone its characteristic probability of differentiation, a property that reflects the likelihood that a cell of this clone will undergo erythrodifferentiation under given conditions. We have examined somatic hybrid cells formed between similar erythroleukemic lines, between phenotypically different erythroleukemic lines, and between erythro. leukemic cells and mouse fibroblasts. Results of these experiments demonstrate that the spontaneous and induced probabilities of differentiation may be altered in an uncoupled fashion, suggesting that each is determined at different steps leading to a common pathway of globin gene expression.
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Murine erythroleukemic cells infected with Friend leukemia virus resemble proerythroblasts morphologically and mature in culture to a normoblast-like stage when treated with dimethylsulfoxide [(CH3)2SO] (1) . This in vitro erythroid differentiation is characterized by the appearance of an erythrocyte membrane antigen (2) , increases in heme synthesis and iron uptake (1) , induction of hemoglobin synthesis (1, 2, 4) , and the accumulation of globin mRNA (5, 6) . The expression of the globin genes can be quantitated precisely and specifically in these cells by use of radioactive, synthetic globin complementary DNA (cDNA) (6) .
Of paramount importance to all further studies on globin gene expression and differentiation in these cells is an assessment of the uniformity of the extent of differentiation in cells within cloned lines. Here we show that relative differences in apparent globin gene expression within and between lines largely reflect differences in the proportion of cells participating in erythroid differentiation rather than uniform differences in the extent to which all cells in clones undergo differentiation. For convenience we propose to call this phenotype of a clone its probability of differentiation, a property which reflects the likelihood that a cell of a clone will undergo differentiation under given conditions. This phenotype is preserved in subclones of cloned erythroleukemic lines, indicating that the probability of differentiation in these lines is controlled by relatively (6) . Cellular RNA added per reaction was varied to yield at least two points within the linear range of hybridization (less than 35%) and the percentage of cytoplasmic RNA that was globin mRNA was calculated by reference to a standard curve for purified 9S mouse globin mRNA assayed under identical conditions. 30% hybridization under these conditions corresponded to 250 pg of pure globin mRNA.
Hybridization of globin [3H]cDNA to cellular DNA to estimate globin gene reiteration per haploid genome was performed as previously described (6) .
RESULTS
Differentiation of Cloned Erythroleukemic Cell Lines. Cloned erythroleukemic lines differ in both their spontaneous and (CH3)2SO-induced levels of globin mRNA (Table 1) . When (CH3)2SO-treated cells of these lines are stained with acid benzidine reagent to reveal hemoglobin accumulation after 5 days' induction, a nonuniform pattern of staining is evident. (14) and an optical path length of 11 ,um ( = measured cell diameter), the absorptance of 20% (= optical density of 0.1) corresponds to a hemoglobin concentration of 0.72 mM.
guanine-resistant subelone of T3-C12 (TG D-3) only a small fraction (less than 5%) become positive under identical growth conditions. To exclude the possibility that this apparent heterogeneity of induction is an artifact due to insensitivity of benzidine staining, we examined the hemoglobin content of individual erythroleukemic cells using a computerassisted microspectrophotometer (13) . An average absorption spectrum of induced T3-C12 cells is shown in Fig. 1 (Fig. 3A) . In the remaining colonies, variable but significant (25-50%) numbers of benzidine positive cells were present. T3-C12 TG D-3, on the other hand, yielded uniformly subclones in (CH3)2S0 which contained scattered (less than 5%) positive cells (Fig. 3B) 0.01% for untreated populations and 0.06% for (CH3)2SO-treated cultures, indicating that the phenotype of the hybrid cells accurately reflects the parental phenotypes.
Hybrid clones of T3-C12 TG D-3 X GM 86 H-11 OulA were all quite similar. These hybrids contained intermediate levels of globin mRNA in the absence of (CH3)2SO but were relatively resistant to further induction by (CH3)2SO (Fig. 4) . Thus, these hybrid cells had a level of spontaneous differentiation intermediate between parental lines, but a (CH3)r SO-induced extent of differentiation more nearly like that of the parent that differentiates less frequently. The specificity of these effects was demonstrated in separate experiments (not shown) in which the concentration of Friend leukemia virus RNA in cytoplasmic RNA of both parents and hybrids was shown to vary independently of globin mRNA. In addition, there is no appreciable change in total cytoplasmic RNA in these cells after (CH3)2SO treatment. Further control experiments demonstrated that co-cultivation of parental lines does not mimic the phenotype observed in the hybrids and that the number of globin genes per haploid content of cell DNA extracted from one hybrid clone was indistinguishable from the low reiteration frequency obtained for the stock erythroleukemic lines.
The limited erythroid differentiation of these hybrids upon (CH3)2SO treatment is reflected at the clonal level as well, as greater than 90% of subclones of hybrid clones grown in (CH3)2S0 resemble those of T3-C12 TG D-3 in having only scattered benzidine positive cells (Fig. 3C) . The nearly complete chromosomal complement of these hybrids (Table 2) makes it unlikely, though not impossible, that material contributed by GM 86 H-il OulA necessary for maximal induction has been lost in these hybrids. Instead, it is likely that factors contributed by T3-C12 TG D-3 to these hybrids result in suppression of cellular differentiation induced by (CH3)2SO. No significant progression in either chromosome number or globin mRNA levels was observed for two hybrid clones studied repeatedly over 20 passages (approximately 100 cell generations). The chromosomal stability of these suspension hybrids under normal growth conditions resembles that of intraspecific mouse fibroblast hybrids (8) . Our findings demonstrate that genetically homogeneous (cloned) populations of erythroleukemic cells do not respond homogeneously to (CH3)2SO induction of erythroid differentiation. Differences in apparent globin gene expression between erythroleukemic cell lines largely reflect differences in the numbers of cells participating in erythroid differentiation in response to (CH3)2SO rather than differences in absolute rates of globin gene transcription or globin mRNA accumulation attainable by induced cells within these lines. We have called this phenotype a clone's characteristic probability of differentiation, that is, the likelihood a cell of this clone will undergo differentiation under given conditions. Cloning experiments indicate that this phenotype is determined by rather stable genetic or epigenetic factors.
Differentiation in Hybrid Erythroleukemic Cells. Hybrid cells formed between erythroleukemic cells with similar phenotypes (GM 86 H-11 OulA and GM 86 TG D-5) resemble the parental lines with respect to their pattern of erythroid differentiation. This indicates that somatic hybridization alone does not introduce significant artifacts and further attests to the relative stability of the genetic or epigenetic elements that determine differentiation in the untreated and induced states in these cells.
In hybrids formed between dissimilar erythroleukemic lines (GM 86 H-11 OulA and T3-C12 TG D-3) the extents of differentiation in the untreated and induced states are uncoupled (Fig. 4) Somatic hybrids formed between mouse fibroblasts and erythroleukemic cells demonstrated apparent extinction of globin expression, similar to that described in other hybrids formed between differentiated and "undifferentiated" cells (18) . Although this extinction probably reflects fundamental differences between these cell types with regard to their commitment to different pathways of differentiation, the consequences of trivial factors (e.g., chromosomal loss or selection against globin expression in fibroblast hybrids) cannot be easily excluded until segregants with regained expression are isolated. The absence of globin mRNA in such hybrids, however, should not be used alone as evidence for the existence of diffusible repressors for globin gene transcription, as our studies suggest that several control steps precede this level. Indeed, the need to distinguish between controls affecting the probability of differentiation as opposed to those regulating the transcription of the globin genes is also essential when agents such as BrdTJ (19) are used to modulate gene expression.
Implications of the Probability of Differentiation Phenotype. These erythroleukemic cells provide a model of a special class of cells which differentiate continuously throughout the lifetime of the individual. Normal hematopoietic precursor cells form a constant, dividing population from which cells are continuously maturing. It is possible that the complex mechanisms that determine the probability of differentiation of erythroleukemic cells are those that also play a role in the maturation of cells of this class.
